Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 67.81% | 67.00% | 60.83% | 58.24% | -19.01% |
Total Receivables | 185.71% | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -46.39% | -60.11% | -65.46% | 36.10% | 23.49% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 64.15% | 62.76% | 57.25% | 58.40% | -17.73% |
|
|||||
Total Current Assets | 64.15% | 62.76% | 57.25% | 58.40% | -17.73% |
Net Property, Plant & Equipment | -5.33% | 8.02% | 10.73% | 130.56% | 130.14% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 38.86% | 10.42% | 205.09% | 22.24% | 12.75% |
Total Assets | 60.97% | 59.67% | 56.98% | 58.69% | -15.15% |
|
|||||
Total Accounts Payable | -87.34% | -49.52% | 9.51% | 124.92% | 307.16% |
Total Accrued Expenses | 30.81% | 40.55% | 120.41% | 142.12% | 135.30% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 47.14% | 168.92% | 165.97% | 156.94% | 100.00% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -4.82% | 21.94% | 92.08% | 136.72% | 168.95% |
|
|||||
Total Current Liabilities | -4.82% | 21.94% | 92.08% | 136.72% | 168.95% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -6.53% | -0.74% | 1.50% | 150.29% | 150.44% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -93.48% | -85.71% | -81.48% | -79.14% | -72.78% |
Total Liabilities | -5.50% | 13.07% | 43.51% | 137.22% | 158.56% |
|
|||||
Common Stock & APIC | 61.02% | 60.99% | 60.80% | 60.76% | 4.30% |
Retained Earnings | -52.47% | -58.97% | -66.92% | -70.13% | -72.24% |
Treasury Stock & Other | 102.10% | -- | -- | -- | -- |
Total Common Equity | 68.00% | 63.07% | 57.62% | 56.71% | -20.78% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 68.00% | 63.07% | 57.62% | 56.71% | -20.78% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 68.00% | 63.07% | 57.62% | 56.71% | -20.78% |
|